These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17889042

  • 41. Amphetamine sensitization in rats as an animal model of schizophrenia.
    Peleg-Raibstein D, Knuesel I, Feldon J.
    Behav Brain Res; 2008 Aug 22; 191(2):190-201. PubMed ID: 18486243
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul 22; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 44. Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration.
    Grasing K, He S, Yang Y.
    Pharmacol Biochem Behav; 2009 Nov 22; 94(1):169-78. PubMed ID: 19698738
    [Abstract] [Full Text] [Related]

  • 45. Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment.
    Jochum T, Boettger MK, Wigger A, Beiderbeck D, Neumann ID, Landgraf R, Sauer H, Bär KJ.
    Behav Brain Res; 2007 Oct 01; 183(1):18-24. PubMed ID: 17599477
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J, Pachuta A, Bochenski M, Silberring J.
    Peptides; 2009 Jun 01; 30(6):1165-72. PubMed ID: 19463751
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects.
    Toussaint M, Delair B, Foulon C, Lempereur N, Vaccher C, Maurice T, Melnyk P.
    Eur Neuropsychopharmacol; 2009 Jul 01; 19(7):504-15. PubMed ID: 19249191
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Measuring thigmotaxis in larval zebrafish.
    Schnörr SJ, Steenbergen PJ, Richardson MK, Champagne DL.
    Behav Brain Res; 2012 Mar 17; 228(2):367-74. PubMed ID: 22197677
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Suppression of opiate withdrawal and cocaine hyperarousal syndromes by buspirone. Possible pharmacotherapeutic applications.
    Aceto MD, Bowman ER.
    Arzneimittelforschung; 1993 Sep 17; 43(9):942-5. PubMed ID: 8240454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.